Most recently, it has been discovered that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to some big range of endogenous opioids. Unlike most opioid receptors, this receptor functions as being a scavenger and doesn't activate